Apr 9, 2024, 09:05 AM by

Tome Biosciences, Inc., the programmable genomic integration (PGI) company, today announces the issuance of US Patent 11,952,571 for “Systems, Methods, and Compositions for Site-Specific Genetic Engineering Using Programmable Addition via Site-Specific Targeting Elements (PASTE)” by the US Patent and Trademark Office. This patent further protects Tome’s foundational PGI technology, integrase-mediated PGI (I-PGI), describes a system capable of performing I-PGI in a mammalian cell, and is exclusively licensed to Tome from MIT.

Apr 9, 2024, 09:05 AM by

Model Medicines has announced the upcoming release of two groundbreaking preprint papers on bioRxiv, detailing significant advances in antiviral and oncology drug discovery using their GALILEO AI platform. The first preprint reveals the discovery of a novel broad-spectrum antiviral target and inhibitor, while the second introduces ChemPrint, a deep learning model that achieved a remarkable 45.5% hit rate in identifying novel inhibitors of challenging oncology targets. These findings build upon Model Medicines' recent successes and underscore the transformative potential of their AI platform in revolutionizing drug discovery.

Apr 9, 2024, 09:05 AM by

Spin-out unites three sites to create a leading global CDMO as further significant investments announced at Holmes Chapel site

Apr 9, 2024, 09:05 AM by

CG Life is acquiring Toolhouse, doubling agency size and strengthening expertise in creating impactful digital experiences connecting with clinical and patient audiences.

Apr 9, 2024, 06:00 AM by User Not Found

Bio-IT World | During the NVIDIA GTC conference held at the San Jose Convention Center and online March 18-21, NVIDIA CEO Jensen Huang highlighted an array of advancements, including new foundation models coming to NVIDIA BioNeMo, a collaboration with Johnson & Johnson MedTech to expand AI’s role in surgical settings, and the launch of over two dozen generative AI microservices to advance areas like digital health, medical technology, and drug discovery.

Apr 8, 2024, 06:00 AM by User Not Found

Bio-IT World | Bio-IT World announced the 2024 Best of Show Finalists and People’s Choice Contenders today, highlighting 26 new products from 27 different companies that will be on display at the Bio-IT World Conference and Expo, April 15-17, in Boston. The Best of Show Awards will honor several new products live at the event during the Best of Show Awards Reception beginning at 5:15 on Tuesday, April 16.

Apr 5, 2024, 08:07 AM by

New MyPhenome test delivers patients and providers with the most comprehensive and actionable insights yet into their obesity type(s).

Apr 5, 2024, 08:07 AM by

Andaman7 Launches AI Supercharged Personal Health Record v5 New advanced AI Simplification, Summarization and Translation features empower patients and improve communication with healthcare providers and researchers.

Apr 5, 2024, 06:00 AM by User Not Found

Bio-IT World | The pace at which CRISPR has transitioned from a research tool to a therapeutic modality is remarkable. Initially targeting genetic diseases, CRISPR holds tremendous promise across various indications, rapidly expanding into oncology and infectious diseases, indicating CRISPR's vast and continual evolution as a modality.

Apr 4, 2024, 07:37 AM by

Universal Brain Expands Executive Team to Accelerate Precision Psychiatry

Apr 4, 2024, 07:37 AM by

Apr 3, 2024, 07:56 AM by

Peerbridge Health’s Remote Device for Early Detection of Heart Failure Achieves 95.7% Success Rate in Trial

Apr 3, 2024, 07:56 AM by

Lindus Health Unveils Versatile “All-in-One Respiratory CRO” Offering Tailored to Respiratory Clinical Trials

Apr 3, 2024, 07:56 AM by

Scope of Industry Risk-Based Quality Management (RBQM) Adoption Revealed CluePoints, the Tufts Center for the Study of Drug Development and PwC publish Comprehensive Assessment of RBQM Adoption in Clinical Trials.

Apr 3, 2024, 06:00 AM by User Not Found

Bio-IT World | The single biggest risk factor for autoimmune disease is being biologically a female and many explanations have been proposed as to why that is, among them sex hormones and the X chromosome with its large number of immune-related genes.

Apr 2, 2024, 07:53 AM by

The RSA Group, a leading life sciences executive search firm, has published the latest of its Talent Equity Reports: “Sustaining a winning position” – an analysis of how Switzerland can continue to lead the life sciences sector in a shifting global market.

Apr 2, 2024, 06:00 AM by User Not Found

Bio-IT World | Miguel Edwards, a partner at DeciBio Consulting, broke down the market outlook for spatial biology at last week’s Precision Medicine TriConference. “We think about this market really as opening up a new dimension of biological insight into tissue analysis,” Edwards said. “You’re seeing the excitement and promise for really improving our understanding of fundamental biology and really driving better therapeutics and better diagnostics.”

Mar 28, 2024, 08:05 AM by

Global genomics solutions provider Integrated DNA Technologies (IDT) is expanding its gene synthesis offerings with a new custom vector onboarding tool.

Mar 28, 2024, 08:05 AM by

Mar 28, 2024, 06:00 AM by User Not Found

Bio-IT World | In the newest episode of Trends from the Trenches, host Stan Gloss speaks with La Barge about his unique perspective on growing biotech businesses. La Barge delves into the challenges he and his team face in gene therapy advancement and how a company—especially one just starting out—can pave the path to successful research.